Relocating health governance: Personalized medicine in times of 'global genes'

Personalized Medicine

Volumn 3, Issue 3, 2006, Pages 349-355

  Prainsack, Barbara ^a   Naue, Ursula ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Governance; Hopes and promises; Public representations of personalized medicine; Self regulation; Soft law

Indexed keywords

ORPHAN DRUG;

ARTICLE; DRUG LEGISLATION; DRUG RESPONSE; ECONOMIC ASPECT; ETHNOLOGY; GENETIC POLYMORPHISM; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL RESEARCH; PATIENT CARE; PERSONALIZED GENOMICS; PHARMACOGENOMICS; POLITICS; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 33747302329     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/17410541.3.3.349     Document Type: Article

References (20)

1. Gurwitz D, Weizman A, Rehavi M: Education: teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine. Trends Pharmacol. Sci. 24(3), 122-125 (2003).
2. Hedgecoe A: The Politics of Personalised Medicine: Pharmacogenetics in the Clinic. Cambridge University Press, Cambridge, UK (2004).
3. Brown N: Hope against hype - accountability in biopasts, presents and futures. Science Studies 16(2), 3-21 (2003).
4. Regalado A: Inventing the pharmacogenomics business. Am. J. Health Syst. Pharm. 56, 40-50 (1999).
5. Roden DM, George AL: The genetic basis of variability in drug responses. Nature Rev. Drug Discov 1, 37-44 (2002).
6. Rose N: The politics of life itself. Theory Culture Society 18 (6), 1-30 (2001).
7. Lemke T: "The Birth of Bio-Politics" - Michel Foucault's lecture at the Collège de France on neo-liberal governmentality. Economy Society 30(2), 190-207 (2001).
8. Corrigan OP: Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report. J. Med. Ethics 31, 144-148 (2005).
9. European Commission: Communication from the Commission to the Council, the European Parliament, the Economic and Social Committee and the Committee of the Regions: Life Science and Biotechnology - A Strategy for Europe. COM (2002) 27 final, January 23, Brussels, Belgium (2002).
10. Chadwick R, Berg K: Solidarity and equity: new ethical frameworks for genetic databases. Nature Rev. Genet. 2, 318-327 (2001).
11. Marshall A: Getting the right drug into the right patient. Nature Biotechnol. 16(Suppl.), 9-16 (1998).
12. Whitman J: The Limits of Global Governance. Routledge, London, UK (2005).
13. The Commission on Global Governance: Our Global Neighborhood: The Report of the Commission on Global Governance. Oxford University Press, Oxford, UK (1995).
14. Lunshof J: Desperate times call for desperate measures. Nature Rev. Genet. 7, 162 (2006).
15. Salter B, Jones M: Biobanks and bioethics: the politics of legitimation. J. Eur. Pub. Policy 12(4), 710-732 (2005).
16. Waldby C: The Visible Human Project: Informatic Bodies and Posthuman Medicine. Routledge, London, UK (2000).
17. Waldby C, Mitchell R: Tissue Economies: Blood, Organs, and Cell Lines in Late Capitalism. Duke University Press, Durham, NC, USA (2006).
18. Rose N, Novas C: Biological Citizenship. In: Global Assemblages. Technology, Politics, and Ethics as Anthropological Problems. Ong A, Collier SJ (Eds), Blackwell Publishing, Malden, USA, 439-463 (2005).
19. Thacker E: The Global Genome: Biotechnology Politics, and Culture. The MIT Press, Cambridge, MA, USA (2005).
20. Kahn J: Misreading race and genomics after BiDil. Nature Genet. 37, 655-656 (2005).